Ligand-regulated peptide aptamers that inhibit the 5′-AMP-activated protein kinase

JOURNAL OF MOLECULAR BIOLOGY

卷:365

Article

Miller, Russell A. ; Binkowski, Brock F. ; Belshaw, Peter J.

关键词: AMPK;    peptide aptamer;    ligand-regulated peptide aptamers;    pseudosubstrate;    substrate inhibition;   

DOI  :  10.1016/j.jmb.2006.07.035

来源: Elsevier

【 摘 要 】

In an effort to extend the peptide aptamer approach, we have developed a scaffold protein that allows small molecule ligand control over the presentation of a peptide aptamer. This scaffold, a fusion of three protein domains, FKBP12, FRB, and GST, presents a peptide linker region for target protein binding only in the absence of the small molecule Rapamycin or other non-immunosuppressive Rapamycin derivatives. Here we describe the characterization of ligand-regulated peptide aptamers that interact with and inhibit the 5'-AMP-activated protein kinase (AMPK). AMPK, a central regulator of cellular energy homeostasis, responds to high cellular AMP/ATP ratios by promoting energy producing pathways and inhibiting energy consuming biosynthetic pathways. We have characterized 15 LiRPs of similar, poly-basic sequence and have determined that they interact with the substrate peptide binding region of both AMPK alpha 1 and alpha 2. These proteins, some of which serve as poor substrates of AMPK, inhibit the kinase as pseudosubstrates in a Rapamycin-regulated fashion in vitro, an effect that is largely competitive with substrate peptide and mediated by an increase in the kinase's apparent K-m, for substrate peptide. This pseudosubstrate inhibition of AMPK by LiRP proteins reduced the AMP stimulation of AMPK in vitro and caused the inhibited state of the kinase to kinetically resemble the basal, unstimulated state of AMPK, providing potential insight into the molecular mechanisms of AMP stimulation of AMPK. (c) 2006 Elsevier Ltd. All rights reserved.

【 授权许可】

Free